|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Endocrine Disease | |||||
| Glucose Intolerance | |||||
| Hyperinsulinemia | |||||
| Impaired Glucose Tolerance | |||||
| Obesity | |||||
| Type II Diabetes Mellitus | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 2 | |||||
| Endocrine System Diseases | |||||
| Hyperinsulinism | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Glucose Metabolism Disorders | |||||
| Hyperglycemia | |||||
| Metabolic Diseases | |||||
| Nutrition Disorders | |||||
| Overnutrition | |||||
| Overweight | |||||
| Signs and Symptoms | |||||
| 4 | Sponsors listed in this trial | ||||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |||||